INV13 15:00-15:30
Guillaume Rousseau, EryPharm, Paris ⓘ
Industrial production of cultured red blood cells: a model for future large-scale cell therapies finally within reach
INV14 15:30-16:00
Pierre Savatier, Stem Cell and Brain Research Institute, Lyon
Interspecies systemic chimeras : a new path for exploring pluripotent stem cell biology and modeling human early development
INV15 16:00-16:30
Christelle Monville, Istem, Evry ⓘ
Retinal pigment epithelial cells derived from human embryonic stem cells disposed on human amniotic membrane: An update on the french RP clinical trial
OR09 16:30-16:45
Carine Bourdais, IRMB, Univ Montpellier, INSERM, CHU Montpellier
Combined cellular and gene therapy to treat primary ciliary dyskinesia
